LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Lucid Diagnostics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.38−0.10 (-21.05%)
Close on Oct 19, 2026
- Market cap
- $69.11M
- P/E (TTM)
- –
- Dividend yield
- –
Lucid Diagnostics Inc. revenue by segment
By business segment
By product or service
By region
From the segment and revenue-disaggregation notes of Lucid Diagnostics's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.